Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype
Cristina Ferreira Almeida, Natércia Teixeira, Georgina Correia‐da‐Silva, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 156-156
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review
Camren G. Heider, Sasha A. Itenberg, Jiajia Rao, et al.
Biology (2022) Vol. 11, Iss. 6, pp. 817-817
Open Access | Times Cited: 64
Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective
Manamele D. Mashabela, Abidemi Paul Kappo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5659-5659
Open Access | Times Cited: 9
A review of the industrial use and global sustainability of Cannabis sativa
Asif Raihan, Tashdid Rahman Bijoy
Global Sustainability Research (2023) Vol. 2, Iss. 4, pp. 1-29
Open Access | Times Cited: 20
Mitochondrial calcium overload contributes to cannabinoid‐induced paraptosis in hormone‐responsive breast cancer cells
Amy de la Harpe, Natasha Beukes, Carminita Frost
Cell Proliferation (2024) Vol. 57, Iss. 10
Open Access | Times Cited: 6
Small Molecule Therapeutics in the Pipeline Targeting for Triple-Negative Breast Cancer: Origin, Challenges, Opportunities, and Mechanisms of Action
Nneoma James, Esther Owusu, Gildardo Rivera, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6285-6285
Open Access | Times Cited: 6
Phytocompounds and Nanoformulations for Anticancer Therapy: A Review
Giuseppina Bozzuto, Annarica Calcabrini, Marisa Colone, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3784-3784
Open Access | Times Cited: 5
Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights
Sabrina Bimonte, Giuseppe Palma, Marco Cascella, et al.
Anticancer Research (2023) Vol. 43, Iss. 3, pp. 993-1000
Open Access | Times Cited: 13
Heterogeneity in hormone-dependent breast cancer and therapy: Steroid hormones, HER2, melanoma antigens, and cannabinoid receptors
Tajda Tavčar Kunstič, Nataša Debeljak, Klementina Fon Tacer
Advances in Cancer Biology - Metastasis (2023) Vol. 7, pp. 100086-100086
Open Access | Times Cited: 12
Targeting cancer metabolic vulnerabilities for advanced therapeutic efficacy
Tobias Achu Muluh, Xing‐sheng Shu, Ying Ying
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114658-114658
Open Access | Times Cited: 12
Molecular Targets of Minor Cannabinoids in Breast Cancer: In Silico and In Vitro Studies
Cristina Ferreira Almeida, Andreia Palmeira, Maria João Valente, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1245-1245
Open Access | Times Cited: 4
Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors
Cristina Ferreira Almeida, Natércia Teixeira, Maria João Valente, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2517-2517
Open Access | Times Cited: 11
Exploring the 1,3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic
Nicola Gambacorta, Valeria Gasperi, Tatiana Guzzo, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115647-115647
Closed Access | Times Cited: 10
Two-Step Cell Death Induction by the New 2-Arachidonoyl Glycerol Analog and Its Modulation by Lysophosphatidylinositol in Human Breast Cancer Cells
Mikhail Akimov, N. M. Gretskaya, Evgenia I. Gorbacheva, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 820-820
Open Access
Effect of cannabinoids on the efficacy and side effects of anticancer therapeutic strategies – Current status of preclinical and clinical research
Robert Ramer, Burkhard Hinz
Pharmacology & Therapeutics (2025), pp. 108851-108851
Closed Access
Meta-analysis of medical cannabis outcomes and associations with cancer
Ryan Castle, James Marzolf, Miranda J. Morris, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Cannabinol improves exemestane efficacy in estrogen receptor-positive breast cancer models: a comparative study with cannabidiol
Cristina Ferreira Almeida, Maria João Valente, Natércia Teixeira, et al.
European Journal of Pharmacology (2025), pp. 177712-177712
Closed Access
Nucleolar sequestration of cannabinoid type-2 receptors in triple-negative breast cancer cells
Linley P Prado-Celis, Rodrigo Zamora-Cárdenas, Javier Alamilla, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0323554-e0323554
Open Access
Natural products as a source of new anticancer chemotypes
Francesco Melfi, Simone Carradori, Noemi Mencarelli, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 11, pp. 721-744
Closed Access | Times Cited: 9
The Interaction of the Endocannabinoid Anandamide and Paracannabinoid Lysophosphatidylinositol during Cell Death Induction in Human Breast Cancer Cells
Mikhail Akimov, N. M. Gretskaya, Evgenia I. Gorbacheva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2271-2271
Open Access | Times Cited: 3
The anti-aromatase and anti-estrogenic activity of plant products in the treatment of estrogen receptor-positive breast cancer
Nicolette J. D. Verhoog, Lee-Maine L. Spies
The Journal of Steroid Biochemistry and Molecular Biology (2024) Vol. 243, pp. 106581-106581
Open Access | Times Cited: 3
Euphorbiasteroid Induces Apoptosis as Well as Autophagy through Modulating SHP-1/STAT3 Pathway in Hepatocellular Carcinoma Cells
Na Young Kim, Gautam Sethi, Jae‐Young Um, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13713-13713
Open Access | Times Cited: 8
Activation of cannabinoid receptors in breast cancer cells improves osteoblast viability in cancer-bone interaction model while reducing breast cancer cell survival and migration
Tueanjai Khunluck, Kornkamon Lertsuwan, Chartinun Chutoe, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Role of key endocannabinoids and their receptors in breast cancer
Mikhail Akimov, Polina V. Dudina, T. V. V’yunova, et al.
Reviews on Clinical Pharmacology and Drug Therapy (2024) Vol. 22, Iss. 1, pp. 41-51
Closed Access | Times Cited: 2
Triple Negative Breast Cancer (TNBC): Cannabis sativa-Role of Phytocannabinoids
Ravindra B. Malabadi, Kiran P. Kolkar, Sadiya MR, et al.
World Journal of Biology Pharmacy and Health Sciences (2024) Vol. 17, Iss. 3, pp. 140-179
Open Access | Times Cited: 1
The molecular anti-metastatic potential of CBD and THC from Lebanese Cannabis via apoptosis induction and alterations in autophagy
Maria Younes, Marissa El Hage, Wassim N. Shebaby, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top